Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Tekmira Pharmaceuticals Corp T.TKM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  TKMR

Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
Price: $16.22 | Change: +$0.89 | %Change: +5.81%
Volume: 34,157 | Day High/Low: 16.24/15.20 | 52 Week High/Low: 34.66/7.95
View modes: 
1 star

expecting ir to get drunk at xmas staff party

spill da beans  rate and reply
1 star

15.75 was hard pop

merry xmas/new year all peace long n strong  rate and reply
1 star


You're right. At this level, I will start looking at call options or selling puts. I have been using a TFSA though and believe I need to switch to a cash account to sell puts.  rate and reply
1 star


I don't see the difference in TKMR. I just like owning this stock, but am considering an options play. I just made a bundle shorting a US shale player, and it was nice making some money just on more
1 star

Howdy Folks

I am back.  I am in.  Got back in thursday...and I got a bunch.  I got some more reading to do.  Hi Tamarcktop.  Have a great weekend everyone.  Oh hey Tamarcktop, you can't just stop posting more
1 star


I hold TKM stock, although I'd consider buying Canadian options if we had 'em.  rate and reply
1 star


This stock will be a drifter until some news drops. It feels like its coming soon. Just out of curiosity... Do you own the stock, options, or both. Just wondering if you are on any certain timeline more
1 star


Is looking at a lot like July-August. We're closing in on our 200 day moving average, and what happened last time we did that? Our stock nearly doubled within a week! With PLK1 data to be released, more
2 stars


Hey Tamaracktop, I'm on here about 5 or so times per day, but just reading as I don't have anything significant to contribute that has not already been posted. I think we'll see a resurgence more
0 stars


I'm done with this board. It's useless. I'll stick to the US chatlines where I at least get some input, whether its agreeing or disagreeing with me . It's a way more interactive experience. more
0 stars


Will somebody please post something or is nobody following this stock anymore? I'm posting on CNN's board too, and I get constant feedback.  rate and reply
0 stars


Look at CCXI today . Yesterday's close $4.49. Trading at $10 premarket. Market cap up $236 million today. CCXI and BLUE are 2 very recent examples of what biotech stocks can do on positive more
1 star


Interesting that there are virtually no posters on this thread. That will change in the near future when the stock hits $25. There are 3 separate news items I expect befor year end: Preliminary more
0 stars

RE:RE:Insider Sell

thanks man, great info. It seems pretty clear that they won't do an offering, and that announcement of a shelf was just because their current one is expiring. Todays action was very interesting, I more
5 stars

RE:Insider Sell

The most significant inference you can confidently make from that sale is that they aren't going to do a secondary offering anytime soon. Were that the case, the sale would have been such a more
0 stars

Insider Sell

What is the significance of that insider sell? Tamaracktop...I'm looking at you for guidance here. You have been a wealth of info, and if I ever met you I would buy you a beer. (made me some $) I more
1 star

RE:Please read published today

Topping $15 on a market down day (and week) means something is probably going on behind the scenes. I accumulated more shares based on future prospects which appear to be strong. The financial more
1 star


Agree that TKMR is a sleeping giant. Their technology is under-rated and not yet fully understood. As a purely financial play, the DoD revenue strengthens their financial position, along with more
4 stars

Please read published today

Tekmira Pharmaceuticals Corp (NASDAQ:TKMR): 6 Analyst have given the stock of Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) a near short term price target of $28.67. The standard deviation reading, more
3 stars


Preliminary results any day now. Testing on 3 separate and distinct types of cancer. Positive results would make the stock go ballistic. The combined markets for a therapies for these cancers more